Tag Archives: MP1032

05/12/
2021

“The Path to the Clinical Trial”

by
by General, Research results
No Comments on “The Path to the Clinical Trial”

A conversation with Dr. Petra Schulz Discussing MetrioPharm’s Phase II Clinical Study in COVID-19

Dr. Petra Schulz, Senior Manager Drug Development at MetrioPharm

MetrioPharm is currently preparing a clinical trial of its lead compound MP1032 in COVID-19. How do you conduct study preparations under pandemic conditions?

The landscape has changed...

Read more

Contact

Ralf Haubert
Marketing Manager
blog@metriopharm.com

Newsletter subscription

Register here for blogging news via e-mail-newsletter.

© MetrioPharm AG 2019